Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

OTTESON JASON G — Acer Therapeutics Inc. insider: 1 transactions · InsiderLens

/ / OTTESON JASON G

OTTESON JASON G

Director at Acer Therapeutics Inc. · on record since Mar 5, 2004
CEO and CFO at Acer Therapeutics Inc. · on record since Mar 5, 2004
10% owner at Acer Therapeutics Inc. · on record since Mar 5, 2004

Insider trading activity of OTTESON JASON G

Transactions on record: 1; since Mar 5, 2004

Open-market buys: 1; $12.5K

Open-market sells: 0

Companies traded: 1; last filing Mar 5, 2004

Figures computed from official regulatory filings — .

Companies where OTTESON JASON G has traded

Acer Therapeutics Inc.1 tx · $12.5K · Mar 5, 2004

Track record of OTTESON JASON G

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of OTTESON JASON G

Co-insiders of OTTESON JASON G

Adduci JeffreyAcer Therapeutics Inc.
Albert & Margaret Alkek FoundationAcer Therapeutics Inc.
Amello JasonAcer Therapeutics Inc.
Andrews William T.Acer Therapeutics Inc.
ASELAGE STEVEAcer Therapeutics Inc.
Bailey GregoryAcer Therapeutics Inc.
BARABE TIMOTHY CAcer Therapeutics Inc.
Beeby ReshenthaAcer Therapeutics Inc.
Birner HubertAcer Therapeutics Inc.
BOVEROUX BROOKSAcer Therapeutics Inc.
BURRIS MICHELLEAcer Therapeutics Inc.
Davis Jefferson EAcer Therapeutics Inc.
DESLATTE DWAYNEAcer Therapeutics Inc.
DUNN JOHN MICHAELAcer Therapeutics Inc.
Fischer StefanAcer Therapeutics Inc.
Frison PaulAcer Therapeutics Inc.
FRITZSCHE R WAYNEAcer Therapeutics Inc.
Gow Robert HAcer Therapeutics Inc.
Hartung Hans-PeterAcer Therapeutics Inc.
Hayden TanyaAcer Therapeutics Inc.
Healey DonAcer Therapeutics Inc.
Hohlfeld LynneAcer Therapeutics Inc.
Hung DavidAcer Therapeutics Inc.
JARKESY GEORGEAcer Therapeutics Inc.
JORDEN DAVID EMERSONAcer Therapeutics Inc.
Joseph DonaldAcer Therapeutics Inc.

This page republishes public regulatory disclosures.

Jutt-Eghbali SalmaAcer Therapeutics Inc.

Kamin TonyAcer Therapeutics Inc.

Klopp John MichaelAcer Therapeutics Inc.

Lau Warren CAcer Therapeutics Inc.

Leatt GaryAcer Therapeutics Inc.

Litowitz Alec NAcer Therapeutics Inc.

Maderis Gail JAcer Therapeutics Inc.

Magnetar Capital Partners LPAcer Therapeutics Inc.

Magnetar Financial LLCAcer Therapeutics Inc.

Marengere LucAcer Therapeutics Inc.

MARXE AUSTIN W & GREENHOUSE DAVID MAcer Therapeutics Inc.

McWilliams DavidAcer Therapeutics Inc.

PALMIN HARRY SAcer Therapeutics Inc.

Paul Bernard HAcer Therapeutics Inc.

Quartel Adrian WAcer Therapeutics Inc.

Radhakrishnan KarthikAcer Therapeutics Inc.

Randall LorinAcer Therapeutics Inc.

Richman MichaelAcer Therapeutics Inc.

Rill Donna RAcer Therapeutics Inc.

Rodriguez BrianAcer Therapeutics Inc.

ROTH MICHAELAcer Therapeutics Inc.

Rouse WilliamAcer Therapeutics Inc.

Schelling ChrisAcer Therapeutics Inc.

SCHUHSLER HELMUTAcer Therapeutics Inc.

Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
Acer Therapeutics Inc.Listing unverified	Mar 5, 2004	Buy	12,500,000	0.00 USD	$12.5K	conv 66First in 12mo	SEC